Partial and radical cystectomy offer comparable oncologic outcomes in well-selected patients with muscle-invasive bladder cancer, according to study findings presented at the 2024 annual meeting of ...

Patients found to have positive lymph nodes after robotic radical cystectomy for muscle-invasive bladder cancer may benefit from treatment de-escalation if they have undetectable circulating tumor DNA ...

Nadofaragene firadenovec offers a 66% probability of cystectomy-free survival at 60 months for BCG-unresponsive NMIBC with CIS ± Ta/T1 disease. The phase 3 study enrolled 107 patients, with 103 ...

The team at EvergreenHealth Women’s Specialty Care, Gynecology treats complex conditions, like endometriosis and fibroids. Sponsored by EvergreenHealth.

Dr. Omar Mian discussed the role of adjuvant radiotherapy in the post-radical cystectomy setting, addressing the following points: Why consider adjuvant radiotherapy after cystectomy? Peri-operative ...

AstraZeneca AZN announced that the FDA has accepted and granted priority review to its supplemental biologics license application (sBLA) seeking expanded use of its blockbuster drug, Imfinzi ...

The US Food and Drug Administration (FDA) has granted priority review to AstraZeneca's supplemental biologics licence ...

AstraZeneca's Imfinzi gains FDA Priority Review for bladder cancer. Key trial data shows improved survival and progression ...

If approved, durvalumab will be the first and only perioperative immunotherapy regimen available for the treatment of ...

Early radical cystectomy can be beneficial and should be performed in patients with refractory T1 tumors or carcinoma in situ before progression to muscle invasion. In this Review I present an ...

Cambridge: AstraZeneca's supplemental Biologics License Application (sBLA) for Imfinzi (durvalumab) has been accepted and ...